RT operates through a unique mechanism as a triple agonist, targeting the GIP, GLP-1, and GCG receptors, with a strong emphasis on GIP receptor activation. This receptor interaction leads to a comprehensive approach to metabolic regulation, significantly impacting both glycemic control and weight loss. Below is an overview of the underlying mechanisms:
RT’s primary mechanism involves potent activation of the GIP receptor, which plays a vital role in appetite regulation by directly affecting the brain’s satiety centers. This reduces hunger, cravings, and overall food intake.
Through GLP-1 receptor activation, rt supports glycemic regulation and enhances satiety. GLP-1 also slows down gastrointestinal motility and delays gastric emptying, leading to increased feelings of fullness after meals.
Activation of the GCG receptor by rt is believed to increase energy expenditure and promote fat oxidation, largely through metabolic actions in the liver. GCG receptor stimulation encourages fat breakdown and elevates metabolic rates. Additionally, it induces “beiging” of white fat, converting it into beige fat with thermogenic properties similar to brown fat, thereby boosting calorie burning and enhancing metabolism.
